Package 60687-935-21

{"route": ["ORAL"], "spl_id": "485a9dee-1c16-7a66-e063-6294a90ab8b8", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["a50eb0b4-1bee-4781-8eba-75e324540d36"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (60687-935-21)  / 1 TABLET in 1 BLISTER PACK (60687-935-11)", "package_ndc": "60687-935-21", "marketing_start_date": "20260104"}], "brand_name": "Ticagrelor", "product_id": "60687-935_485a9dee-1c16-7a66-e063-6294a90ab8b8", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "60687-935", "generic_name": "Ticagrelor", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ticagrelor", "active_ingredients": [{"name": "TICAGRELOR", "strength": "60 mg/1"}], "application_number": "ANDA208596", "marketing_category": "ANDA", "marketing_start_date": "20260104", "listing_expiration_date": "20271231"}